Literature DB >> 8635041

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute.

C Zippin1, D Lum, B F Hankey.   

Abstract

BACKGROUND: To ascertain the quality of data entering a population-based reporting system, an essential requirement is to study levels of completeness of case-ascertainment and reporting. This study represents an effort to quantify completeness of case reporting in the SEER (Surveillance, Epidemiology, and End Results) Program of the National Cancer Institute.
METHODS: Hospitals in each of the participating SEER areas were stratified according to their annual hospital cancer caseload for the year 1987. Within each caseload stratum, a random sample of hospitals was selected for inclusion in this study. Files in the medical record, pathology, and radiation oncology departments in each hospital were reviewed for SEER reportable cases. These cases were then matched against SEER case listings to identify unreported cases.
RESULTS: The crude estimated completeness of reporting for 1987 in the six participating SEER areas was 97.7% and the registry-caseload standardized rate was 96.8%. Variation was noted by SEER registry, hospital cancer caseload, and casefinding source (hospital department). Three-quarters of unreported cases were of invasive disease and one-fourth were in situ, primarily of the cervix uteri.
CONCLUSIONS: There is variation in completeness of casefinding among SEER registries, hospital size, and hospital department source. Additional factors that appear to be related to case ascertainment are cancer site or type and who performs the casefinding function (hospital registry or central registry staff).

Entities:  

Mesh:

Year:  1995        PMID: 8635041     DOI: 10.1002/1097-0142(19951201)76:11<2343::aid-cncr2820761124>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  92 in total

1.  Hospital volume and survival of breast cancer patients in Connecticut.

Authors:  A P Polednak
Journal:  Am J Public Health       Date:  1999-06       Impact factor: 9.308

2.  Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography.

Authors:  Daniel Polsky; Katrina A Armstrong; Thomas C Randall; Richard N Ross; Orit Even-Shoshan; Paul R Rosenbaum; Jeffrey H Silber
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

3.  Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.

Authors:  Melissa M Thrall; Heidi J Gray; Rebecca Gaston Symons; Noel S Weiss; David R Flum; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2011-04-15       Impact factor: 5.482

4.  Sex disparities in cancer mortality and survival.

Authors:  Michael B Cook; Katherine A McGlynn; Susan S Devesa; Neal D Freedman; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

5.  Interaction of area-level socioeconomic status and UV radiation on melanoma occurrence in California.

Authors:  Christina A Clarke; Lisa M Moy; Susan M Swetter; John Zadnick; Myles G Cockburn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-26       Impact factor: 4.254

6.  Blood transfusions and the subsequent risk of cancers in the United States elderly.

Authors:  Regina Riedl; Eric A Engels; Joan L Warren; Andrea Berghold; Winnie Ricker; Ruth M Pfeiffer
Journal:  Transfusion       Date:  2013-01-16       Impact factor: 3.157

7.  Variation in insurance status by patient demographics and tumor site among nonelderly adult patients with cancer.

Authors:  Stephen R Grant; Gary V Walker; B Ashleigh Guadagnolo; Matthew Koshy; Pamela K Allen; Usama Mahmood
Journal:  Cancer       Date:  2015-04-27       Impact factor: 6.860

8.  Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer.

Authors:  Christopher G Slatore; Alyson J Littman; David H Au; Jessie A Satia; Emily White
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

9.  Diagnostic delay and complications for older adults with multiple myeloma.

Authors:  Christopher R Friese; Gregory A Abel; Lysa S Magazu; Bridget A Neville; Lisa C Richardson; Craig C Earle
Journal:  Leuk Lymphoma       Date:  2009-03

10.  Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status.

Authors:  Gary V Walker; Stephen R Grant; B Ashleigh Guadagnolo; Karen E Hoffman; Benjamin D Smith; Matthew Koshy; Pamela K Allen; Usama Mahmood
Journal:  J Clin Oncol       Date:  2014-08-04       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.